NeoStem Expected To Have Short and Long Term Value Drivers
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
Citigroup [NYSE:CITI] pricing GSVC’s $100 million raise this week. As of end of trading Sept 19th, GSVC stock is trading at about $14.37 and seems undervalued for several reasons.
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed a therapeutic DNA based composition to treat HIV, GenePro.
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
QLT (TSE:QLT) (NASDAQ:QLTI) announced Wednesday it received two fast track designations from the U.S. FDA
OneMedRadio interviewed Tom Moore, CEO and Chairman of the Board of Directors of Advaxis [OTC:ADXS]. He discusses the company’s novel immunotherapy technology.
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The conference will feature over 70 company presentations. Below are some interesting technologies attendees can expect to hear from.
Considered to be bankers for the growth industry, Rodman and Renshaw goes beyond the life science industries.
OneMedRadio interviewed President and Director Deborah Jenkins Hutchinson and got a glimpse into this emerging growth company.
Copyright © 2025 | WordPress Theme by MH Themes